179 related articles for article (PubMed ID: 25978141)
21. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
22. Graft Materials and Biologics for Spinal Interbody Fusion.
D'Souza M; Macdonald NA; Gendreau JL; Duddleston PJ; Feng AY; Ho AL
Biomedicines; 2019 Sep; 7(4):. PubMed ID: 31561556
[TBL] [Abstract][Full Text] [Related]
23. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate.
Baskin DS; Ryan P; Sonntag V; Westmark R; Widmayer MA
Spine (Phila Pa 1976); 2003 Jun; 28(12):1219-24; discussion 1225. PubMed ID: 12811263
[TBL] [Abstract][Full Text] [Related]
24. Anatomic feasibility of a new endopelvic approach for iliac crest bone harvesting.
Le Pape S; Du Pouget L; Cloche T; Campana M; Obeid I; Boissiere L; Vital JM
Surg Radiol Anat; 2016 Dec; 38(10):1191-1194. PubMed ID: 27160584
[TBL] [Abstract][Full Text] [Related]
25. Clinical assessment of 115 cases of hindfoot fusion with two different types of graft: Allograft+DBM+bone marrow aspirate versus autograft+DBM.
Tricot M; Deleu PA; Detrembleur C; Leemrijse T
Orthop Traumatol Surg Res; 2017 Sep; 103(5):697-702. PubMed ID: 28416462
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
27. Bioglue and allograft versus autograft for craniovertebral instrumented fusion.
Goel A
World Neurosurg; 2014 Dec; 82(6):1050-1. PubMed ID: 23403346
[No Abstract] [Full Text] [Related]
28. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
[TBL] [Abstract][Full Text] [Related]
29. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
Park DK; Kim SS; Thakur N; Boden SD
Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
[TBL] [Abstract][Full Text] [Related]
30. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
31. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
Stambough JL; Clouse EK; Stambough JB
Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
[TBL] [Abstract][Full Text] [Related]
32. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
Schimandle JH; Boden SD; Hutton WC
Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
[TBL] [Abstract][Full Text] [Related]
33. Bone morphogenetic protein in spine surgery: current and future uses.
Even J; Eskander M; Kang J
J Am Acad Orthop Surg; 2012 Sep; 20(9):547-52. PubMed ID: 22941797
[TBL] [Abstract][Full Text] [Related]
34. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
35. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion.
Buttermann GR
Spine J; 2008; 8(3):426-35. PubMed ID: 17977799
[TBL] [Abstract][Full Text] [Related]
36. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
[TBL] [Abstract][Full Text] [Related]
37. Use of allograft bone for posterior C1-2 fusion.
Hillard VH; Fassett DR; Finn MA; Apfelbaum RI
J Neurosurg Spine; 2009 Oct; 11(4):396-401. PubMed ID: 19929334
[TBL] [Abstract][Full Text] [Related]
38. Osteoconductive bone graft extenders in posterolateral thoracolumbar spinal fusion: a systematic review.
Alsaleh KA; Tougas CA; Roffey DM; Wai EK
Spine (Phila Pa 1976); 2012 Jul; 37(16):E993-1000. PubMed ID: 22414999
[TBL] [Abstract][Full Text] [Related]
39. C1-C2 fusion: promoting stability, reducing morbidity.
Lubelski D; Benzel EC
World Neurosurg; 2014 Dec; 82(6):1052-4. PubMed ID: 23459271
[No Abstract] [Full Text] [Related]
40. Bone morphogenetic proteins for spinal fusion.
Carlisle E; Fischgrund JS
Spine J; 2005; 5(6 Suppl):240S-249S. PubMed ID: 16291119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
